Journal Of Clinical Oncology (jco) Podcast
Using BCR-ABL Transcript Levels After 3 Months of Therapy on Imatinib is the Best Way to Predict Long-Term Outcome for Patients with CML Treated with Imatinib
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:08:55
- Mas informaciones
Informações:
Sinopsis
The study by Marin et al is another milestone in our understanding how to manage CML patients on tyrosine kinase inhibitors.
